Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qing Re Xiao Yan Wan versus placebo for upper respiratory tract infection
ChiCTR-TRC-10001105Phase 4Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Dec 2010
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in upper respiratory infection (URI) comparing Qing Re Xiao Yan Wan with Placebo (2 arms). Primary endpoint: 3-day cure rate. Started Dec 2010; status: completed.
02
Drugs
Qing Re Xiao Yan Wan
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR-TRC-10001105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001105.